Hikma Pharmaceuticals PLC (HKMPY)
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.
$43.50+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-15.8%
The outlook
Hikma Pharmaceuticals PLC currently reads as leaning bullish based on above its 50- & 200-day averages, 55% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range55% of the way from its 52-week low to high
Market cap
$4.54B
52-wk high
$53.26
52-wk low
$31.80
50-day avg
$40.58
200-day avg
$40.50
Trailing P/E
12.0